AntibioticDB

CRS3123 (REP3123 )

Aminoacyl-tRNA synthetase inhibitor (methionyl tRNA synthetase [MetRS] inhibitor)

Crestone, USA

2007

Highest development stage: Phase 1
Development status: Active
Gram-positive activity
Mechanism of Action/Target pathogen: Clostridium difficile infection
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10991
Source: https://www.crestonepharma.com/index.php/cdi
Citation (1): https://www.ncbi.nlm.nih.gov/pubmed/28584140
Citation (2): https://www.ncbi.nlm.nih.gov/pubmed/28134686
Citation (3): http://jac.oxfordjournals.org/content/63/5/954.long
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/16744283